Our metabolic analysis of MYC-amplified medulloblastoma revealed upregulation in the metabolism of nucleotides, glutathione, the hexosamine biosynthetic pathway, the urea cycle and amino acids compared to normal brain. The gene discussed is MYC; the disease is medulloblastoma.